Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study.
Sánchez-Guijo FM, Durán S, Galende J, Boqué C, Nieto JB, Balanzat J, Gracia A, García I, Avellaneda-Molina C, Moreno MV, Luño-Fernandez E, Hermosilla M, Sanchez-Varela JM, Dios A, López-Garrido P, Giraldo P, Bargay J, Domingo JM, Soler A, Salinas R, del Cañizo MC. Sánchez-Guijo FM, et al. Among authors: dios a. Leuk Res. 2011 Sep;35(9):1184-7. doi: 10.1016/j.leukres.2011.01.017. Epub 2011 Feb 12. Leuk Res. 2011. PMID: 21316760 Clinical Trial.
Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation.
de Arriba de la Fuente F, Durán MS, Álvarez MÁ, Sanromán IL, Dios AM, Ríos Tamayo R, García R, González MS, Prieto E, Bárez A, Escalante F, Tejedor A, Ballesteros M, Cabañas V, Capote FJ, Couto C, Garzón S, González-Pardo M, Mateos Manteca MV. de Arriba de la Fuente F, et al. Among authors: dios am. Semin Hematol. 2018 Oct;55(4):189-196. doi: 10.1053/j.seminhematol.2017.09.002. Epub 2017 Oct 13. Semin Hematol. 2018. PMID: 30502846 Review.
Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot Study.
Redondo S, De Dios A, Gomis-Pastor M, Esquirol A, Aso O, Triquell M, Moreno ME, Riba M, Ruiz J, Blasco A, Tobajas E, González I, Sierra J, Martino R, García-Cadenas I. Redondo S, et al. Among authors: de dios a. Transplant Cell Ther. 2023 Jun;29(6):385.e1-385.e8. doi: 10.1016/j.jtct.2023.03.016. Epub 2023 Mar 21. Transplant Cell Ther. 2023. PMID: 36948273 Free article.
Unplanned Excision of Soft Tissue Sarcomas of the Extremities in a Low-to-Middle-Income Country.
Wang EHM, Araneta KTS, Gaston CLL, Rubio DAT, de Dios AMV, Cañal JPA, Goleta-Dy AN, Alcasabas APA, Odoño EG, Atun JML, Fernando GY, Dimayuga CCD, Quintos AJD. Wang EHM, et al. Among authors: de dios amv. Ann Surg Oncol. 2023 Jun;30(6):3681-3689. doi: 10.1245/s10434-023-13188-x. Epub 2023 Feb 17. Ann Surg Oncol. 2023. PMID: 36800129 Free PMC article. Review.
Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy.
Gharbi SI, Pelletier LA, Espada A, Gutiérrez J, Sanfeliciano SMG, Rauch CT, Ganado MP, Baquero C, Zapatero E, Zhang A, Benach J, Russell AM, Cano L, Gomez S, Broughton H, Pulliam N, Perez CM, Torres R, Debets MF, de Dios A, Puig O, Hilgers MT, Lallena MJ. Gharbi SI, et al. Among authors: de dios a. NPJ Breast Cancer. 2022 Dec 28;8(1):133. doi: 10.1038/s41523-022-00503-0. NPJ Breast Cancer. 2022. PMID: 36577758 Free PMC article. No abstract available.
Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy.
Gharbi SI, Pelletier LA, Espada A, Gutiérrez J, Sanfeliciano SMG, Rauch CT, Ganado MP, Baquero C, Zapatero E, Zhang A, Benach J, Russell AM, Cano L, Gomez S, Broughton H, Pulliam N, Perez CM, Torres R, Debets MF, de Dios A, Puig O, Hilgers MT, Lallena MJ. Gharbi SI, et al. Among authors: de dios a. NPJ Breast Cancer. 2022 Nov 29;8(1):126. doi: 10.1038/s41523-022-00494-y. NPJ Breast Cancer. 2022. PMID: 36446794 Free PMC article.
102 results